Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Published 18/09/2023, 18:25
© Reuters.  Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

  • SCWorx Corp. (NASDAQ: WORX) shares jumped 111% to $0.4000.
  • Avinger, Inc. (NASDAQ: AVGR) surged 63.2% to $6.75 amid the company announcing the commercial launch of its Tigereye ST image-guided CTO crossing device.
  • SeqLL Inc. (NASDAQ: SQL) shares climbed 47.2% to $19.50 after the company announced the date of its cash and stock dividend.
  • Perspective Therapeutics, Inc. (NASDAQ: CATX) shares climbed 39.1% to $0.2851 after falling 42% on Friday.
  • Nikola Corporation (NASDAQ: NKLA) rose 33% to $1.58 after the company announced the appointment of a new chief operating officer.
  • MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) gained 29.1% to $3.90. Mira Pharmaceuticals shared data and research that positions MIRA1a as a potential future alternative prescription medication with properties not found in THC as well as the potential for fewer side effects.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares climbed 26.7% to $0.3513. T2 Biosystems said it issued inducement awards to four new employees.
  • Trinity Place Holdings Inc. (NYSE: TPHS) gained 18.7% to $0.4690.
  • ContraFect Corporation (NASDAQ: CFRX) jumped 18.3% to $0.67. ContraFect reported submission of IND application to the FDA for its development candidate CF-370.
  • Kineta, Inc. (NASDAQ: KA) gained 16.1% to $2.24. Kineta announced a new research agreement to evaluate VISTA Biomarker Expression.
  • Green Plains Partners LP (NASDAQ: GPP) jumped 16% to $15.98 after entering a definitive merger agreement with Green Plains Inc. (NASDAQ: GPRE).
  • Cabaletta Bio, Inc. (NASDAQ: CABA) surged 13.4% to $17.92. Wells Fargo maintained Cabaletta Bio with an Overweight and raised the price target from $14 to $39.
  • Amprius Technologies, Inc. (NYSE: AMPX) rose 13.2% to $4.4699.
  • Aenza S.A.A. (NYSE: AENZ) gained 13.1% to $2.59.
  • China Green Agriculture, Inc. (NYSE: CGA) surged 13.1% to $1.99.
  • Vivani Medical, Inc. (NASDAQ: VANI) gained 11.9% to $0.9850.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) jumped 11.6% to $5.88. Iovance Biotherapeutics Director Wayne P Rothbaum acquired a total of 5,000,000 shares an average price of $5.30.
  • Matinas BioPharma Holdings, Inc. (NYSE: MTNB) rose 11.5% to $0.1450.
  • Cibus, Inc. (NASDAQ: CBUS) gained 11.4% to $18.62.
  • MariaDB plc (NYSE: MRDB) surged 9.4% to $0.4678. The board of MariaDB confirms that it has received an unsolicited non-binding indicative proposal from Runa Capital II to acquire 100% of the issued 67,705,445 ordinary shares of the company other than those shares already owned by Runa.
  • TradeUP Acquisition Corp. (NASDAQ: UPTD) shares climbed 9.1% to $9.51 after falling 29% on Friday.
  • Zapp Electric Vehicles Group Limited (NASDAQ: ZAPP) gained 8.3% to $1.17.
  • ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) surged 8.1% to $11.90. JP Morgan upgraded ZIM Integrated Shipping from Neutral to Overweight and announced a $15.4 price target.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers

  • Earlyworks Co., Ltd (NASDAQ: ELWS) shares dipped 36.2% to $0.8427. Earlyworks, during July, priced its IPO of 1.2 million ADSs at $5.00 per ADS.
  • STRATA Skin Sciences, Inc. (NASDAQ: SSKN) fell 30.9% to $0.6911.
  • AERWINS Technologies Inc. (NASDAQ: AWIN) shares fell 25.4% to $0.1439 after surging 50% on Friday.
  • MSP Recovery, Inc. (NASDAQ: LIFW) shares fell 21.7% to $0.1472 after jumping around 238% on Friday.
  • AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) fell 21.4% to $0.1139. AgriFORCE Growing Systems announced commercial launch and first purchase order for its AgriFORCE-RCS Hydroxyl Device.
  • Scilex Holding Company (NASDAQ: SCLX) declined 17.3% to $1.86. Scilex recently announced the completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with acute LBP.
  • Rubicon Technologies, Inc. (NYSE: RBT) fell 17.2% to $0.3580. Rubicon Technologies reported a 1-for-8 reverse stock split.
  • Chanson International Holding (NASDAQ: CHSN) declined 16.3% to $2.76.
  • Ayro, Inc. (NASDAQ: AYRO) fell 15% to $3.30.
  • Canopy Growth Corporation (NASDAQ: CGC) tumbled 14.8% to $1.15 after the company announced a private placement of up to $50 million.
  • UpHealth, Inc. (NYSE: UPH) fell 14.5% to $1.0256.
  • Micromobility.com Inc. (NASDAQ: MCOM) dipped 14.1% to $0.0704.
  • Tenax Therapeutics, Inc. (NASDAQ: TENX) tumbled 14.1% to $0.2922.
  • NexImmune, Inc. (NASDAQ: NEXI) declined 13.8% to $0.2241.
  • Sezzle Inc. (NASDAQ: SEZL) fell 13.5% to $11.61.
  • Cara Therapeutics, Inc. (NASDAQ: CARA) dipped 13.4% to $2.0250.
  • Nuvalent, Inc. (NASDAQ: NUVL) fell 12.7% to $41.36. Nuvalent will present preliminary dose-escalation data from its ongoing ALKOVE-1 Phase 1/2 trial of Nvl-655 at the 35th AACR-NCI-EORTC Symposium.
  • FOXO Technologies Inc. (NASDAQ: FOXO) fell 11% to $0.1219 after gaining 11% on Friday.
  • DocGo Inc. (NASDAQ: DCGO) fell 10.4% to $5.11. DocGo named Lee Bienstock as CEO effective Sept. 15.
  • GigaCloud Technology Inc. (NASDAQ: GCT) fell 10.2% to $10.28.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) declined 9.8% to $2.3350.
  • Unity Software Inc. (NYSE: U) fell 8.8% to $33.13. On Sept. 17,Unity posted “.. We apologize for the confusion and angst the runtime fee policy we announced on Tuesday caused. We are listening, talking to our team members, community, customers, and partners, and will be making changes to the policy.”
  • Safety Shot Inc (NASDAQ: SHOT) fell 8.5% to $1.40.
  • 180 Life Sciences Corp. (NASDAQ: ATNF) fell 6.8% to $0.7713 after climbing 45% on Friday.
  • Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) shares fell 6.4% to $0.36 after surging 25% on Friday.
  • OKYO Pharma Limited (NASDAQ: OKYO) fell 5.1% to $1.88. OKYO Pharma announced closing of $4.0 million registered direct offering of ordinary shares.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.